Strong Buy
Average AnalystN/A
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 86.33
0.00 (0.00%)
N/A
0.19M
USD 94.67(+9.66%)
Symbol | Name | Exchange | CNS's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
Amundi MSCI Pacific ex Ja.. | PA | 5.27 % | 0.00 % | 0.00 (0.00%) | USD0.03B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
This stock has shown below median earnings growth in the previous 5 years compared to its sector